TerrAscend (TSNDF) Other Non Operating Income (2021 - 2026)
TerrAscend's (TSNDF) quarterly Other Non Operating Income came in at $428000.0 in Q1 2026, up 1119.05% year-on-year from $35109.4 in Q1 2025, and down 81.55% on a QoQ basis from $2.3 million in Q4 2025.
TerrAscend (TSNDF) Other Non Operating Income (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Other Non Operating Income data on file, last reported at $428000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 1119.05% year-over-year to $428000.0 in Q1 2026; TTM through Mar 2026 was $3.7 million, a 80.03% increase from a year earlier, with the FY2025 full-year figure at $888000.0, down 81.69% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $428000.0, down from $2.3 million in the prior quarter.
- Over the last five years, Other Non Operating Income for TSNDF reached as high as $4.3 million in Q4 2024 and fell as low as -$2.1 million in Q3 2024.
- Historically, Other Non Operating Income has averaged $172705.9 across 5 years, with a median of -$42000.0 in 2025.
- Across the five-year window, Other Non Operating Income slumped 3786.67% in 2022 and jumped 2551.43% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at -$881000.0 in 2022, then soared by 80.14% to -$175000.0 in 2023, then soared by 2551.43% to $4.3 million in 2024, then tumbled by 45.92% to $2.3 million in 2025, then slumped by 81.55% to $428000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $428000.0 in Q1 2026, $2.3 million in Q4 2025, and $291000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 428,000.00 |
| Dec 31, 2025 | 2.32 Mn |
| Sep 30, 2025 | 291,000.00 |
| Jun 30, 2025 | 648,000.00 |
| Mar 31, 2025 | -42,000.00 |
| Dec 31, 2024 | 4.29 Mn |
| Sep 30, 2024 | -2.10 Mn |
| Jun 30, 2024 | -104,000.00 |
| Mar 31, 2024 | -285,000.00 |
| Dec 31, 2023 | -175,000.00 |
| Sep 30, 2023 | -120,000.00 |
| Jun 30, 2023 | 101,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | -881,000.00 |
| Sep 30, 2022 | -583,000.00 |
| Jun 30, 2022 | -1.15 Mn |
| Mar 31, 2022 | 271,000.00 |
| Dec 31, 2021 | 4.81 Mn |
| Sep 30, 2021 | -15,000.00 |
| Jun 30, 2021 | 947,000.00 |